Retina Northwest, PC

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Macular degeneration5 trials

Phase

• Phase 33 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Completed3 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Apellis Pharmaceuticals, Inc.1 trial
• Astellas Pharma Global Development, Inc.1 trial
• EyeBiotech Ltd.1 trial
• Novartis Pharmaceuticals1 trial
• Stealth BioTherapeutics Inc.1 trial

Running trials

• Recruiting

  A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

  NCT07440225· Phase 2/3· EyeBiotech Ltd.· Source

  Contact: Study Coordinator

• Active, not recruiting

  ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)

  NCT06373731· Phase 3· Stealth BioTherapeutics Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Macular degeneration1 recruiting

Closed trials

• Completed

  Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

  NCT05536297· Phase 3· Astellas Pharma Global Development, Inc.· Source

• Completed

  A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

  NCT05230537· Phase 2· Novartis Pharmaceuticals· Source

• Completed

  An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

  NCT04770545· Phase 3· Apellis Pharmaceuticals, Inc.· Source